4-Chlorobenzo[b]thiophene CAS 66490-33-3 Ucoceko >98.0% (GC) Brexpiprazole Intermediate Factory

Inkcazelo emfutshane:

Igama leMichiza: 4-Chlorobenzo[b]thiophene

CAS: 66490-33-3

Ubunyulu: >98.0% (GC)

Imbonakalo: Ulwelo olungenambala

Umbindi weBrexpiprazole (CAS: 913611-97-9)

Umgangatho ophezulu, iMveliso yoRhwebo

E-Mail: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Ruifu Chemical Supply Brexpiprazole Intermediates
Brexpiprazole CAS 913611-97-9
7-Hydroxyquinolinone CAS 70500-72-0
4-Bromobenzo[b]thiophene CAS 5118-13-8
1-(1-Benzothiophen-4-yl)piperazine Hydrochloride CAS 913614-18-3
7-(4-Chlorobutoxy)quinolin-2(1H)-enye CAS 913613-82-8
4-Chlorobenzo[b]thiophene CAS 66490-33-3

Iipropati zeMichiza:

Igama leMchiza	4-Chlorobenzo[b]thiophene
Izithethantonye	4-Chloro-Benzo[b]thiophene;4-Chloro-1-Benzothiophene;4-Chlorobenzothiophene
Inombolo yeCAS	66490-33-3
Inombolo yeCAT	RF-PI1983
Ubume beStokhwe	Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli	C8H5ClS
Ubunzima beMolekyuli	168.64
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Ulwelo olungenambala
Ubunyulu / Indlela yokuHlalutya	>98.0% (GC)
Ukungcola ngokupheleleyo	<2.00%
I-Infrared Spectrum	Iyahambelana neSakhiwo
NMR	Iyahambelana neSakhiwo
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	Umbindi weBrexpiprazole (CAS: 913611-97-9)

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile eneFluorinated, 25kg/Drum, okanye ngokwemfuno yomthengi

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma

Izinto eziluncedo:

FAQ:

Isicelo:

I-4-Chlorobenzo [b] i-thiophene (i-CAS: 66490-33-3) i-Intermediate of Brexpiprazole (CAS: 913611-97-9).I-Brexpiprazole lichiza eliyinoveli le-antipsychotic elisebenza njenge-serotonin ® dopamine umsebenzi wemodyuli kwaye ibonise ukusebenza njengonyango lokongezelela kwizigulana ezinoxinzelelo olukhulu loxinzelelo (MDD).Ichiza libonisa iphrofayili ekhethekileyo ye-pharmacological, esebenza njenge-agonist inxalenye ye-serotonin 5-HT1A kunye ne-dopamine D2 receptors kunye ne-antagonist epheleleyo ye-5-HT2A kunye ne-noradrenaline α1B / 2C i-receptors, kunye ne-subnanomolar efanayo ebophelelayo.Ichiza, elaphuhliswa ngu-Otsuka kunye no-Lundbeck, livunyiwe kwi-2015 yi-FDA yonyango lwe-schizophrenia kunye nonyango lokuncedisa ukudakumba.I-Brexpiprazole ithathwa ngokubanzi njengendlalifa ye-Otsuka ye-antipsychotic drug aripiprazole (igama lorhwebo i-Abilify) eliphelelwe ilungelo labo lomenzi ngo-Agasti ka-2014.